|
|
|
|
|
|
|
|
|
|
CONCLUSION: Continued efforts with combination therapy designed to target multiple steps in apoptotic pathways may not only improve the efficacy of TRAIL-mediated therapies, but may also improve quality of life for ovarian cancer patients by reducing toxicity associated with cancer therapy.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.